Project Grant HT94252310474
Award Date
7/1/23
Completion Date
6/30/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Illinois has been awarded a $1,465,443 federal Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support advanced biomedical research focused on the "Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors" over a 3-year period from September 1, 2025 to August 31, 2028. The Military Medical Research and Development program provides funding for innovative medical...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,422,430.00 to the University of Illinois to conduct research on the effects of transfemoral socket design on hip muscle co-contraction, balance, and mobility. The project aims to investigate how changes to prosthetic socket design can impact these important factors for individuals with transfemoral amputations. The University of Illinois, as the prime...
The University of Illinois was awarded a $293,978.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a research project titled "COGNITION, VASCULAR FUNCTION, AND PHYSICAL ACTIVITY IN MULTIPLE SCLEROSIS" which will run from November 1, 2024 to October 31, 2026. The project aims to investigate the relationship between cognition, vascular function, and physical activity in individuals with multiple...
This $284,659 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will fund research at the University of Illinois to investigate the "Regeneration of the Bone Marrow Hematopoietic Niche by Jagged1-Expressing Myeloid-Derived Suppressor Cells." The research, spanning from December 1, 2024 to November 30, 2026, aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
The University of Illinois received a four-year, $2,068,139 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into exercise training programs to manage major depressive disorder symptoms experienced by individuals with multiple sclerosis. The University of Illinois will conduct this research from 2021 through 2025 in Chicago, Illinois. Through supporting innovative medical...
The University of Illinois was awarded a $719,550 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. The grant, with an April 1, 2024 award date and March 31, 2027 completion date, will support research on the TRKA-MLK3 axis as an actionable target in triple-negative breast cancer. The project aims to advance scientific understanding and develop new treatments related to this specific type of breast cancer, which is a key...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...